Company: PTHS
Filing Date: 2025-09-03
Form Type: 8-K
Source: 0001753926-25-001425
Chunk: 0

Company: Pelthos Therapeutics Inc.
Filing Date: 2025-09-03
Form: 8-K
Item: Item 7.01
Chunk 0
---
Item 7.01. Regulation FD Disclosure.

On September 2, 2025, Pelthos Therapeutics
Inc. (the “ Company”) issued a press release announcing that its Chief Executive Officer, Scott Plesha, and Chief Financial
Officer, Francis Knuettel II, will present at the Wells Fargo 2025 Healthcare Conference in Boston, Massachusetts. Management’s
presentation will take place on Wednesday, September 3, 2025 at 1:30 p. m. Eastern Time. A webcast of the presentation will be available
on the Events and Presentations pages of the Company’s website at https://pelthos. com. Archived replays will be available
for 90 days following the conference. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.

At the conference, the Company will provide
an update on its product pipeline and discuss recent business developments, including its commercial launch of ZELSUVMITM.
The presentation materials furnished herewith as Exhibit 99.2 (the “ Presentation Materials”) will be used in connection
with such presentation, are incorporated into this Item 7.01 by reference and will be posted on the Company’s website at
https://pelthos. com. Information contained on the Company’s website is not incorporated by reference into and should not
be considered to be part of this Current Report on Form 8-K.